dacarbazine has been researched along with dihydroxyphenylalanine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrup, G; Hafström, L; Jönsson, PE; Rorsman, H | 1 |
| Armata, J; Balwierz, W; Depowska, T; Moryl-Bujakowska, A; Strzeszyński, J | 1 |
| Agrup, G; Arnbjörnsson, E; Hafström, L; Jönsson, PE; Rorsman, H | 1 |
| Ichihashi, M; Inoi, T; Mishima, Y; Mojamdar, M | 2 |
| Gadjeva, V; Raikova, E; Zheleva, A | 1 |
| De Sanctis, V; Di Stefano, D; Enrici, RM; Esposito, V; Falco, T; Lanzetta, G; Minniti, G; Scaringi, C | 1 |
| Consales, A; Garrè, ML; Morana, G; Nozza, P; Piccardo, A; Rossi, A | 1 |
| Carideo, L; Cicone, F; Mamede, M; Minniti, G; Russo, I; Scaringi, C; Scopinaro, F | 1 |
1 review(s) available for dacarbazine and dihydroxyphenylalanine
| Article | Year |
|---|---|
[A suggested program of combined treatment of Hodgkin's disease in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Dihydroxyphenylalanine; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Radiotherapy, High-Energy; Vinblastine; Vincristine | 1988 |
1 trial(s) available for dacarbazine and dihydroxyphenylalanine
| Article | Year |
|---|---|
[Treatment of malignant melanoma with DTIC--therapeutic effects determined by 5-S-cysteinyldopa changes in the urine (proceedings)].
Topics: Clinical Trials as Topic; Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Drug Evaluation; Humans; Melanoma; Skin Neoplasms; Triazenes | 1978 |
7 other study(ies) available for dacarbazine and dihydroxyphenylalanine
| Article | Year |
|---|---|
Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopa.
Topics: Adult; Aged; Brain Neoplasms; Cysteinyldopa; Dacarbazine; Digestive System; Dihydroxyphenylalanine; Female; Humans; Infusions, Intra-Arterial; Male; Melanoma; Middle Aged; Palliative Care; Remission, Spontaneous | 1980 |
[Therapeutic evaluation of human malignant melanoma by urinary 5-S-cysteinyldopa dynamics: chemotherapy and surgery].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Prognosis; Vincristine | 1984 |
[Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
Topics: Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Female; Humans; Lymphoma; Melanoma; Middle Aged; Skin Neoplasms | 1982 |
Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the DOPA-oxidase activity of tyrosinase.
Topics: Animals; Antineoplastic Agents, Alkylating; Catalysis; Cyclic N-Oxides; Dacarbazine; Dihydroxyphenylalanine; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Lomustine; Melanoma, Experimental; Mice; Molecular Structure; Monophenol Monooxygenase; Neoplasm Proteins; Nitrosourea Compounds; Oxidation-Reduction; Piperidines; Plant Proteins; Spectrophotometry; Spin Labels; Structure-Activity Relationship; Triazenes; Tumor Cells, Cultured | 1999 |
Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Radiosurgery; Retrospective Studies; Temozolomide | 2013 |
Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treate
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Child, Preschool; Dacarbazine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Ganglioglioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Temozolomide | 2013 |
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Temozolomide; Tumor Burden | 2018 |